Ranolazine
Brand name: Ranolazine Er
Rank #247 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$51.6M
Total Cost
381,631
Total Claims
$51.6M
Total Cost
10,838
Prescribers
$135
Cost per Claim
65,901
Beneficiaries
713,052
30-Day Fills
$4,765
Avg Cost/Provider
35
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$51.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $51.6M total
Top Prescribers of Ranolazine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Henry Yee | Cardiology | Alhambra, CA | 1,570 | $289K |
| 2 | Harry Balian | Cardiology | Glendale, CA | 1,914 | $249K |
| 3 | Loi Nguyen | Cardiology | Houston, TX | 565 | $182K |
| 4 | Prakash Shah | Cardiology | Milwaukee, WI | 1,024 | $132K |
| 5 | Samir Mewar | Cardiology | Columbus, GA | 732 | $121K |
| 6 | Dannis Hood | Interventional Cardiology | Ringgold, GA | 918 | $110K |
| 7 | Mauricio Melhado | Cardiology | West Palm Beach, FL | 857 | $100K |
| 8 | Terrence Posluszny | Cardiology | Mcallen, TX | 677 | $84K |
| 9 | Deepak Kapadia | Cardiology | Madisonville, KY | 496 | $80K |
| 10 | Dakshesh-Kumar Parikh | Cardiology | Victoria, TX | 955 | $80K |
| 11 | Arkady Stern | Family Practice | Los Angeles, CA | 477 | $78K |
| 12 | Ajay Jain | Cardiology | Statesboro, GA | 752 | $76K |
| 13 | Garo Pehlevanian | Cardiology | Los Angeles, CA | 429 | $73K |
| 14 | Ravichandra Boyella | Cardiology | Tucson, AZ | 413 | $71K |
| 15 | Yili Huang | Cardiology | Elmhurst, NY | 423 | $67K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 244 | Belumosudil Mesylate (Rezurock) | $52.3M | 2,280 |
| 245 | Pegloticase (Krystexxa) | $52.2M | 1,134 |
| 246 | Estrogens, Conjugated (Premarin) | $52.0M | 130,171 |
| 247 | Ranolazine (Ranolazine Er) | $51.6M | 381,631 |
| 248 | Epoetin Alfa (Epogen) | $51.4M | 34,952 |
| 249 | Nifedipine (Nifedipine Er) | $51.2M | 1,249,866 |
| 250 | Clobetasol Propionate (Clobetasol Propionate) | $51.2M | 758,575 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology